Apoptosis-inducing effect of a new bisphosphonate, YM529, on various hematopoietic tumor cell lines

Biological and Pharmaceutical Bulletin

Volumn 26, Issue 1, 2003, Pages 96-100

  Nishida, Shozo ^a   Kikuichi, Shigeru ^a   Haga, Hisae ^a   Yoshioka, Shohei ^a   Tsubaki, Masonobu ^a   Fujii, Katsuki ^a   Irimajiri, Kiyohiro ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

Apoptosis; Bisphosphonate; Hematopoietic tumor cell; YM529

Indexed keywords

ANTINEOPLASTIC AGENT; INCADRONIC ACID; MINODRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; IMIDAZOLE DERIVATIVE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; HEMATOPOIETIC CELL; HISTIOCYTIC LYMPHOMA; HUMAN; HUMAN CELL; LYMPHATIC LEUKEMIA; MYELOMA; PROMYELOCYTIC LEUKEMIA; TUMOR CELL; TUMOR CELL LINE; BLOOD DISEASE; CELL CULTURE; CELL MEMBRANE POTENTIAL; CELL STRAIN HL 60; CELL STRAIN K 562; CELL STRAIN U937; CELL SURVIVAL; INTRACELLULAR MEMBRANE; LEUKEMIA CELL LINE; MITOCHONDRION; PATHOLOGY; PHYSIOLOGY;

APOPTOSIS; CELL SURVIVAL; DIPHOSPHONATES; HEMATOLOGIC NEOPLASMS; HL-60 CELLS; HUMANS; IMIDAZOLES; INTRACELLULAR MEMBRANES; JURKAT CELLS; K562 CELLS; MEMBRANE POTENTIALS; MITOCHONDRIA; TUMOR CELLS, CULTURED; U937 CELLS;

EID: 0038044620     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.26.96     Document Type: Article

References (21)

1. Russell R. G G., Rogers M. J., Bone, 25, 97-106 (1999).
2. Watts N. B , Harris S. T., Genant H K , Wasnich R. D., Miller P D., Jackson R. D., Licata A. A., Ross P., Woodson G. C., 3rd, Yanover M. J., N Engl J Med., 323, 73-79 (1990).
3. Altman R. D., Johnston C. C., Khairi M. R. A., Wellman H., Serafini A. N., Sankey R R., N Engl J Med., 289, 1379-1384 (1973).
4. Hughes D. E , Wright K. R , Uy H. L., Sasaki A., Yoneda T , Roodman G. D., Mundy G. R., Boyce B. F., J Bone Miner. Res, 10, 1478-1487 (1995).
5. Rodan G. A , Fleish H. A., J. Clin Invest., 97, 2692-2696 (1996).
6. Rogers M. J., Chilton K. M., Coxon F. P., Lawry J., Smith M. O., Suri S., Russell R. G., J Bone Miner. Res., 11, 1482-1491 (1996).
7. Boonekamp P. M., Lianne J. A., Wee-Pals V. D., Lennep M. M. L. V. W., Thesing C W., Bijvoet O. L. M., Bone Miner. Res, 1, 27-39 (1986).
8. Huges D. E , MacDonald B. R , Russell R. G. G., Gowen M., J. Clin. Invest , 83, 1930-1935 (1989).
9. Nishikawa M., Akatsu T., Katayama Y , Yasutomo S., Kado S., Kugai N., Yamamoto M , Nagata N., Bone, 18, 9-14 (1996).
10. Fast D. K , Dowse R. F. C., Neuman W. F , Fleish H., Biochem. J, 172, 97-107 (1978).
11. Reitsma P. H., Teitelbaum S. L., Bijvoet O. L., Kahn A. J., J Clin Invest, 70, 927-933 (1982)
12. Yoneda T , Michigami T., Yi B., Williams P. J., Nicwolna M., Hiraga T., Cancer, 88, 2979-2988 (2000).
13. Boissier S., Magnetto S., Frappart L., Cuzin B., Ebetino F. H., Delmas P. D., Clezardin P., Cancer Res., 57, 3890-3894 (1997).
14. Shipman C. M., Rogers M. J., Apperley J. F., Russell R. G., Croucher P I., Br. J Haematol., 98, 665-672 (1997).
15. Aparicio A., Gardner A., Tu Y., Savage A , Berenson J., Kichtenstein A., Leukemia, 12, 220-229 (1998).
16. Benford H. L., Frith J. C., Auriola S., Monkkonen J , Rogers M. J., Mol. Pharmcol., 55, 131-140 (1999).
17. Usui T., Kawakarm R., Watanabe T , Higuchi S., J Chromatogr., 652, 67-72 (1994)
18. Sasaki A., Kitamura K., Alcaide R. E , Tanaka T., Suzuki A., Etho Y., Matsumura T., Int. J. Cancer, 77, 279-285 (1998).
19. Takahashi R., Shimazaki C., Inaba T., Okano A., Hatsuse M., Okamoto A., Hirai H., Ashihara E., Nakagawa M., Leukemia Res., 25, 77-83 (2001).
20. Rogers M J., Chilon K. M , Cixib F. P., Lawry J., Smith M. O., Sun S., Russell G G., Bone Miner Res., 11, 1482-1491 (1996).
21. Senaratne S. G , Pirianov G., Mansi J. L , Arnett T. R , Colston K W., Br J Cancer, 82, 1459-1468 (2000).